Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease
(NASDAQ: VYGR) Delayed: 3.72 --0 (-0%)
Previous Close $3.72    52 Week High $30.54 
Open $3.69    52 Week Low $8.12 
Day High $3.82    P/E N/A 
Day Low $3.69    EPS $0.00 
Volume 573,588